0S9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Syros Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.8012 EUR 13.87%

Market Cap: €50.5m

S	Syros Pharmaceuticals Inc F:0S9	US
	Wal Mart de Mexico SAB de CV F:4GNB	MX
P	Papa John's International Inc F:PP1	US
D	DRDGOLD Ltd XMUN:DUB1	ZA
A	AT&T Inc XHAM:SOBA	US
D	Deutsche Post AG XMUN:DHL	DE
S	Shangri-La Asia Ltd XMUN:SHN	HK

Profitability Summary

Syros Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-28 892%

Negative 3Y Average Operating Margin

-6 337%

Declining Operating Margin

-1 151% > -28 892%

Negative Net Margin

-25 341%

Negative 3Y Average Net Margin

-5 750%

Declining Net Margin

-754% > -25 341%

Negative Free Cash Flow Margin

-25 910%

Negative 3Y Average Free Cash Flow Margin

-5 670%

Declining Free Cash Flow Margin

-1 061% > -25 910%

Negative ROE

-777%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-464%

Declining ROIC

-376% > -448%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.